SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001516551-24-000034
Filing Date
2024-03-04
Accepted
2024-03-04 16:23:48
Documents
15
Period of Report
2024-02-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K skye-20240229.htm   iXBRL 8-K 32472
2 EX-99.1 a240304_skyejenkinsboard.htm EX-99.1 11902
  Complete submission text file 0001516551-24-000034.txt   167186

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20240229.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20240229_lab.xml EX-101.LAB 22082
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20240229_pre.xml EX-101.PRE 11528
16 EXTRACTED XBRL INSTANCE DOCUMENT skye-20240229_htm.xml XML 2537
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 24715247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)